Arsani William

Insider Reports History

Location
Carlsbad, CA
Signature
/s/ Mustapha Parekh, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Arsani William:

Company Role Class Num Shares Value Price $ Report Date Ownership
Design Therapeutics, Inc. Director Common Stock 2,655,000 $13,938,750 $5.25 13 Aug 2025 By Logos Global Master Fund LP
Design Therapeutics, Inc. Director Common Stock 1,000,000 $5,250,000 $5.25 13 Aug 2025 By Logos Opportunities Fund II LP
Design Therapeutics, Inc. Director Stock Option (right to buy) 19,000 10 Jun 2025 Direct

Insider Reports Filed by Arsani William

Symbol Company Period Transactions Value $ Form Type Role Filing Time
DSGN Design Therapeutics, Inc. 13 Aug 2025 2 -$2,953,791 4 Director 14 Aug 2025, 16:15
DSGN Design Therapeutics, Inc. 10 Jun 2025 1 $0 4 Director 12 Jun 2025, 16:30
DSGN Design Therapeutics, Inc. 09 Aug 2024 1 -$3,463,214 4 Director 12 Aug 2024, 16:30
DSGN Design Therapeutics, Inc. 13 Jun 2024 1 $0 4 Director 17 Jun 2024, 17:00
DSGN Design Therapeutics, Inc. 28 Aug 2023 2 $5,373,650 4 Director 30 Aug 2023, 18:02
DSGN Design Therapeutics, Inc. 31 May 2023 1 $0 4 Director 02 Jun 2023, 16:31
DSGN Design Therapeutics, Inc. 15 Jun 2022 1 $0 4 Director 16 Jun 2022, 17:08
DSGN Design Therapeutics, Inc. 21 Mar 2022 1 $474,680 4 Director 22 Mar 2022, 19:28
DSGN Design Therapeutics, Inc. 31 Aug 2021 1 $618,000 4 Director 02 Sep 2021, 17:06
DSGN Design Therapeutics, Inc. 30 Mar 2021 3 $14,000,000 4/A Director 06 Sep 2023, 17:13